Psychemedics Staff

Marijuana Legalization: What Employers Need to Know in 2025

by
Marijuana Legalization
As of January 2025, the legal status of marijuana varies significantly across the United States, with each state adopting its own regulations regarding medical and recreational use. The map below categorizes states based on their marijuana laws as of November 4, 2024: Legal for Recreational and Medical Use (Recreational): States where both recreational and medical ... Read more

Substance Abuse Trends to Watch in the Workforce This Year

by
As we enter into a new year, substance abuse remains a critical concern for employers across industries. The workplace reflects broader societal trends, and shifts in substance use patterns can directly impact employee safety, productivity, and well-being. Understanding these trends enables employers to proactively address potential challenges and adapt policies to maintain a safe and ... Read more

How Fentanyl Awareness Programs Can Save Lives on Campus

by
The rise of fentanyl, a potent synthetic opioid, has transformed the landscape of drug use and overdose risks across the United States. College campuses and schools, which should be safe spaces for learning and personal growth, are not immune to this crisis. Education institutions face an urgent need to address the dangers posed by fentanyl ... Read more

Psychemedics Corporation Announces Reverse and Forward Stock Split

by
DALLAS, TX December 2, 2024 (GLOBE NEWSWIRE) – Psychemedics Corporation (Nasdaq: PMD) (the “Company”), the world’s leading provider of hair testing for drugs of abuse, today announced that, following the approval of the Company’s stockholders at its Annual Meeting of Stockholders held on November 25, 2024, the Company’s Board of Directors has approved a 1-for-5,000 reverse ... Read more

Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders

by
Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, reminds its stockholders to vote ahead of the Company’s upcoming annual meeting of stockholders scheduled for November 25, 2024.  Each stockholder’s vote is important.  The Company’s Board of Directors recommends that stockholders vote "FOR" each proposal at the annual meeting. Instructions for voting your shares ... Read more

The Future of Drug Testing in Education: Key Insights from the 2024 Psychemedics Education Insights Report

by
As drug use and substance abuse continue to be a pervasive issue in educational environments, ensuring the safety and well-being of students and staff remains a top priority. Educational institutions must adopt Health & Wellness Initiatives using advanced drug screening methods to stay ahead of evolving drug trends, which can negatively impact academic performance, mental ... Read more

Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing

by
Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, is excited to announce the release of its first-ever Education Insights Report. This report provides an in-depth analysis of drug trends within educational institutions, shedding light on the growing challenges schools face in maintaining a drug-free environment for students and staff. ... Read more

The Rise of Ketamine: Understanding the Growing Trend and the Value of Hair Testing

by
Rise of Ketamine
In recent years, ketamine, an anesthetic and dissociative drug, has emerged as both a therapeutic tool and a substance of abuse. Initially known for its use in veterinary medicine, ketamine has gained traction in the medical community for its potential in treating depression and PTSD. However, its recreational use has also surged, raising significant concerns ... Read more

Psychemedics Corporation Launches New Ketamine Hair Testing Service

by
Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, is proud to announce the launch of its new ketamine hair testing solution. This innovative testing method marks a significant advancement in the detection and prevention for a drug-free workplace and community.  Ketamine, a powerful dissociative anesthetic and emerging drug of abuse, poses a growing ... Read more

Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock

by
DALLAS, TX, August 12, 2024 – Psychemedics Corporation (Nasdaq:PMD) (“Psychemedics” or the “Company”) today announced that a Transaction Committee (the “Transaction Committee”) of the Board of Directors of the Company (the “Board”)  comprised of independent directors has recommended, and the Board has approved, a plan to cease the registration of the Company’s common stock under ... Read more